• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Impact of Metformin on Systemic Metabolism and Survival of Patients With Advanced Pancreatic Neuroendocrine Tumors.

作者信息

Vernieri Claudio, Pusceddu Sara, de Braud Filippo

机构信息

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

IFOM, The FIRC Institute of Molecular Oncology, Milan, Italy.

出版信息

Front Oncol. 2019 Sep 20;9:902. doi: 10.3389/fonc.2019.00902. eCollection 2019.

DOI:10.3389/fonc.2019.00902
PMID:31616628
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6763756/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ff0/6763756/7b911ba60f87/fonc-09-00902-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ff0/6763756/7b911ba60f87/fonc-09-00902-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ff0/6763756/7b911ba60f87/fonc-09-00902-g0001.jpg

相似文献

1
Impact of Metformin on Systemic Metabolism and Survival of Patients With Advanced Pancreatic Neuroendocrine Tumors.二甲双胍对晚期胰腺神经内分泌肿瘤患者全身代谢及生存的影响
Front Oncol. 2019 Sep 20;9:902. doi: 10.3389/fonc.2019.00902. eCollection 2019.
2
Impact of systemic and tumor lipid metabolism on everolimus efficacy in advanced pancreatic neuroendocrine tumors (pNETs).全身性和肿瘤脂质代谢对依维莫司治疗晚期胰腺神经内分泌肿瘤（pNETs）的疗效的影响。
Int J Cancer. 2019 Apr 1;144(7):1704-1712. doi: 10.1002/ijc.32042. Epub 2019 Jan 7.
3
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues.二甲双胍的使用与接受依维莫司和/或生长抑素类似物治疗的糖尿病合并胰腺神经内分泌肿瘤患者的无进展生存期延长相关。
Gastroenterology. 2018 Aug;155(2):479-489.e7. doi: 10.1053/j.gastro.2018.04.010. Epub 2018 Apr 13.
4
The potential role of metformin in the treatment of patients with pancreatic neuroendocrine tumors: a review of preclinical to clinical evidence.二甲双胍在胰腺神经内分泌肿瘤患者治疗中的潜在作用：临床前至临床证据综述
Therap Adv Gastroenterol. 2020 Jul 31;13:1756284820927271. doi: 10.1177/1756284820927271. eCollection 2020.
5
Metformin with everolimus and octreotide in pancreatic neuroendocrine tumor patients with diabetes.二甲双胍联合依维莫司和奥曲肽用于糖尿病胰腺神经内分泌肿瘤患者
Future Oncol. 2016 May;12(10):1251-60. doi: 10.2217/fon-2015-0077. Epub 2016 Feb 18.
6
The Impact of Diabetes Mellitus and Metformin Treatment on Survival of Patients with Advanced Pancreatic Cancer Undergoing Chemotherapy.糖尿病和二甲双胍治疗对接受化疗的晚期胰腺癌患者生存的影响。
Cancer Res Treat. 2016 Jan;48(1):171-9. doi: 10.4143/crt.2014.292. Epub 2015 Mar 13.
7
The Influence of Metformin on Serum Carbohydrate Antigen 19-9 (CA 19-9) Levels in Type 2 Diabetes Mellitus Patients.二甲双胍对2型糖尿病患者血清糖类抗原19-9（CA 19-9）水平的影响
J Assoc Physicians India. 2018 Mar;66(3):38-41.
8
Can metformin change the prognosis of pancreatic cancer? Retrospective study for pancreatic cancer patients with pre-existing diabetes mellitus type 2.二甲双胍能否改变胰腺癌的预后？对合并2型糖尿病的胰腺癌患者的回顾性研究。
Dig Liver Dis. 2016 Apr;48(4):435-40. doi: 10.1016/j.dld.2015.12.006. Epub 2015 Dec 21.
9
Systemic Therapies for Advanced Pancreatic Neuroendocrine Tumors.晚期胰腺神经内分泌肿瘤的全身治疗
Hematol Oncol Clin North Am. 2016 Feb;30(1):119-33. doi: 10.1016/j.hoc.2015.09.005. Epub 2015 Oct 23.
10
Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis.二甲双胍对糖尿病胰腺癌患者具有生存获益：一项系统评价与荟萃分析。
Oncotarget. 2017 Apr 11;8(15):25242-25250. doi: 10.18632/oncotarget.15692.

引用本文的文献

1
The clinical potentials of combining paclitaxel-based chemotherapy regimen with metformin in cancer treatment: A systematic review and Meta-analysis.基于紫杉醇的化疗方案与二甲双胍联合用于癌症治疗的临床潜力：一项系统评价和Meta分析
Transl Oncol. 2025 Jun 11;59:102438. doi: 10.1016/j.tranon.2025.102438.
2
Visceral Obesity Is Associated with Shorter Progression-Free Survival in Well-Differentiated Gastro-Entero-Pancreatic Neuroendocrine Neoplasia.内脏肥胖与高分化胃肠胰神经内分泌肿瘤的无进展生存期缩短相关。
J Clin Med. 2022 Oct 12;11(20):6026. doi: 10.3390/jcm11206026.
3
Impact of Diabetes and Metformin Use on Enteropancreatic Neuroendocrine Tumors: Post Hoc Analysis of the CLARINET Study.

本文引用的文献

1
Metformin and pancreatic cancer survival: Real effect or immortal time bias?二甲双胍与胰腺癌生存：真实效应还是不朽时间偏倚？
Int J Cancer. 2019 Oct 1;145(7):1822-1828. doi: 10.1002/ijc.32254. Epub 2019 Mar 25.
2
Impact of systemic and tumor lipid metabolism on everolimus efficacy in advanced pancreatic neuroendocrine tumors (pNETs).全身性和肿瘤脂质代谢对依维莫司治疗晚期胰腺神经内分泌肿瘤（pNETs）的疗效的影响。
Int J Cancer. 2019 Apr 1;144(7):1704-1712. doi: 10.1002/ijc.32042. Epub 2019 Jan 7.
3
Type 2 Diabetes in Neuroendocrine Tumors: Are Biguanides and Statins Part of the Solution?
糖尿病及二甲双胍的使用对肠胰神经内分泌肿瘤的影响：CLARINET研究的事后分析
Cancers (Basel). 2021 Dec 23;14(1):69. doi: 10.3390/cancers14010069.
4
Integrated or Independent Actions of Metformin in Target Tissues Underlying Its Current Use and New Possible Applications in the Endocrine and Metabolic Disorder Area.二甲双胍在其当前应用的靶组织中的综合或独立作用及其在内分泌和代谢紊乱领域新的可能应用。
Int J Mol Sci. 2021 Dec 2;22(23):13068. doi: 10.3390/ijms222313068.
5
Implications of neuroendocrine tumor and diabetes mellitus on patient outcomes and care: a matched case-control study.神经内分泌肿瘤和糖尿病对患者预后及护理的影响：一项配对病例对照研究。
Future Sci OA. 2021 Feb 15;7(5):FSO684. doi: 10.2144/fsoa-2020-0190.
6
Impact of diabetes on prognosis of gastric cancer patients performed with gastrectomy.糖尿病对接受胃切除术的胃癌患者预后的影响。
Chin J Cancer Res. 2020 Oct 31;32(5):631-644. doi: 10.21147/j.issn.1000-9604.2020.05.08.
神经内分泌肿瘤中的 2 型糖尿病：二甲双胍和他汀类药物是解决方案的一部分吗？
J Clin Endocrinol Metab. 2019 Jan 1;104(1):57-73. doi: 10.1210/jc.2018-01455.
4
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues.二甲双胍的使用与接受依维莫司和/或生长抑素类似物治疗的糖尿病合并胰腺神经内分泌肿瘤患者的无进展生存期延长相关。
Gastroenterology. 2018 Aug;155(2):479-489.e7. doi: 10.1053/j.gastro.2018.04.010. Epub 2018 Apr 13.
5
The Global Epidemic of the Metabolic Syndrome.代谢综合征的全球流行。
Curr Hypertens Rep. 2018 Feb 26;20(2):12. doi: 10.1007/s11906-018-0812-z.
6
A Nationwide Population-Based Study on the Survival of Patients with Pancreatic Neuroendocrine Tumors in The Netherlands.一项基于荷兰全国人口的胰腺神经内分泌肿瘤患者生存情况研究。
World J Surg. 2018 Feb;42(2):490-497. doi: 10.1007/s00268-017-4278-y.
7
Targeting Cancer Metabolism: Dietary and Pharmacologic Interventions.靶向癌症代谢：饮食与药物干预
Cancer Discov. 2016 Dec;6(12):1315-1333. doi: 10.1158/2159-8290.CD-16-0615. Epub 2016 Nov 21.
8
Type 2 diabetes mellitus.2 型糖尿病。
Nat Rev Dis Primers. 2015 Jul 23;1:15019. doi: 10.1038/nrdp.2015.19.
9
Effect of Metformin Use on Survival in Resectable Pancreatic Cancer: A Single-Institution Experience and Review of the Literature.二甲双胍在可切除胰腺癌患者生存中的作用：单机构经验及文献综述
PLoS One. 2016 Mar 11;11(3):e0151632. doi: 10.1371/journal.pone.0151632. eCollection 2016.
10
Metformin with everolimus and octreotide in pancreatic neuroendocrine tumor patients with diabetes.二甲双胍联合依维莫司和奥曲肽用于糖尿病胰腺神经内分泌肿瘤患者
Future Oncol. 2016 May;12(10):1251-60. doi: 10.2217/fon-2015-0077. Epub 2016 Feb 18.